Lansoprazole
- Product NDC
- 21130-019
- 11-digit product format
- 211300019
- Labeler code
- 21130
- Product ID
- 21130-019_ef523ae9-f41b-4faf-8a6f-6cd4538e6be1
- Type
- HUMAN OTC DRUG
- Nonproprietary name
- Lansoprazole
- Dosage form
- CAPSULE, DELAYED RELEASE
- Route
- ORAL
- Labeler
- Safeway, Inc.
- Application
- ANDA202727
- Marketing category
- ANDA
- Marketing start
- 2012-12-31
- Marketing end
- 0000-00-00
- Substance
- LANSOPRAZOLE
- Active strength
- 15 mg/1
- NDC exclude flag
- E
- Listing certified through
- 2017-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 21130-019-14 | Lansoprazole | 14 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 14 | | 2 |
| 21130-019-14 | Lansoprazole | 1 in 1 BOX | CAPSULE, DELAYED RELEASE | 1 | | 2 |
| 21130-019-28 | Lansoprazole | 14 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 14 | | 2 |
| 21130-019-28 | Lansoprazole | 2 in 1 BOX | CAPSULE, DELAYED RELEASE | 2 | | 2 |
| 21130-019-42 | Lansoprazole | 14 in 1 BOTTLE | CAPSULE, DELAYED RELEASE | 14 | | 2 |
| 21130-019-42 | Lansoprazole | 3 in 1 BOX | CAPSULE, DELAYED RELEASE | 3 | | 2 |
DailyMed Socrata Ingredients#
Ingredient, Type, UNII table| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|
| LANSOPRAZOLE | ACTIVE INGREDIENT | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| LANSOPRAZOLE | ACTIVE MOIETY | 0K5C5T2QPG | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| D&C RED NO. 33 | INACTIVE INGREDIENT | 9DBA0SBB0L | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| D&C YELLOW NO. 10 | INACTIVE INGREDIENT | 35SW5USQ3G | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| FD&C BLUE NO. 1 | INACTIVE INGREDIENT | H3R47K3TBD | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| FD&C RED NO. 40 | INACTIVE INGREDIENT | WZB9127XOA | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| GELATIN | INACTIVE INGREDIENT | 2G86QN327L | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| HYPROMELLOSES | INACTIVE INGREDIENT | 3NXW29V3WO | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| MAGNESIUM CARBONATE | INACTIVE INGREDIENT | 0E53J927NA | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER (1:1) | INACTIVE INGREDIENT | 74G4R6TH13 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| POLYETHYLENE GLYCOLS | INACTIVE INGREDIENT | 3WJQ0SDW1A | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| POLYSORBATE 80 | INACTIVE INGREDIENT | 6OZP39ZG8H | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| SILICON DIOXIDE | INACTIVE INGREDIENT | ETJ7Z6XBU4 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| STARCH, CORN | INACTIVE INGREDIENT | O8232NY3SJ | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| SUCROSE | INACTIVE INGREDIENT | C151H8M554 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| TALC | INACTIVE INGREDIENT | 7SEV7J4R1U | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
| TITANIUM DIOXIDE | INACTIVE INGREDIENT | 15FIX9V2JP | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 21130-019 | LANSOPRAZOLE CAPSULE, DELAYED RELEASE [SAFEWAY, INC.] | 2 | Legacy NDC, 6 package rows | 20131220_5cd41b0a-190d-4460-a536-aa401dc0abb4.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Status |
|---|
| 21130-019-14 | 21130001914 | 14 in 1 BOTTLE | Historical |
| 21130-019-28 | 21130001928 | 14 in 1 BOTTLE | Historical |
| 21130-019-42 | 21130001942 | 14 in 1 BOTTLE | Historical |